Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-14 @ 9:00 AM
Study NCT ID:
NCT00082212
Status:
TERMINATED
Last Update Posted:
2010-04-09
First Post:
2004-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA225-046
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
ImClone LLC
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |